Sort
48,018 grants matching “immunotherapy”
LIAI Epitope Validation Center: Characterization of Allergen specific T Cells
$613,699Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2017 · AI
JH-TIE Admin Core
$613,693Jonathan P Schneck · Johns Hopkins University · P41 · FY2019 · EB
TARGETING ANGIOGENESIS WITH TOXIN-VEGF FUSION PROTEINS
$613,618Sibtech, Inc. · R44 · FY2002 · CA
Translational Studies in Progressive Multifocal Leukoencephalopathy
$613,604Irene Cortese · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
$613,413James Louis Rubenstein · University Of California, San Francisco · R01 · FY2021 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$613,358Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Programming of CD8+ T Cell Tolerance by B Cell APC
$613,334Stephen Philip Schoenberger · La Jolla Institute For Immunology · R01 · FY2009 · AI
Mucosal Chemokines and CD8+ T Cell Immunity to Genital Herpes
$613,293Lbachir Benmohamed · University Of California-Irvine · R01 · FY2019 · AI
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients
$613,285Annette M Molinaro · University Of California, San Francisco · P50 · FY2025 · CA
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$613,109Molly A Hughes · University Of Virginia · R01 · FY2023 · AI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
$613,106Brock Clarke Christensen · Dartmouth College · R01 · FY2020 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$613,059Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Dissecting high-risk cell states in neuroblastoma
$613,054Adam David Durbin · St. Jude Children'S Research Hospital · R37 · FY2024 · CA
Structure, Function and Antigenicity of Coronavirus Spike Proteins
$613,032Jason Scott McLellan · University Of Texas At Austin · R01 · FY2019 · AI
Structure, Function and Antigenicity of Coronavirus Spike Proteins
$613,032Jason Scott McLellan · University Of Texas At Austin · R01 · FY2020 · AI
Structure, Function and Antigenicity of Coronavirus Spike Proteins
$613,032Jason Scott McLellan · University Of Texas At Austin · R01 · FY2021 · AI
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$613,008Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2023 · NS
A digital intervention to improve skin self-examination among melanoma survivors
$612,975Sharon L Manne · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Radiation and dendritic cells to hepatomas to improve immunotherapy response
$612,951Sean S Park · Mayo Clinic Rochester · R01 · FY2024 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
$612,841Ryan C Fields · Washington University · R01 · FY2020 · CA
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT
$612,765Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT
$612,765Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT
$612,765Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Project 1 - Evolutionary and ecological dynamics of tumor-host interactions
$612,755Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells
$612,705Hongjun Wang · Medical University Of South Carolina · R01 · FY2024 · DK